Compare ACAD & AVAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACAD | AVAL |
|---|---|---|
| Founded | 1993 | 1994 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.1B |
| IPO Year | 2000 | 2011 |
| Metric | ACAD | AVAL |
|---|---|---|
| Price | $17.18 | $3.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 3 |
| Target Price | ★ $30.21 | $5.07 |
| AVG Volume (30 Days) | ★ 2.4M | 227.5K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 4.25% |
| EPS Growth | ★ 69.12 | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | ★ $726,437,000.00 | N/A |
| Revenue This Year | $19.55 | $9.63 |
| Revenue Next Year | $13.34 | $11.85 |
| P/E Ratio | $34.47 | ★ $12.86 |
| Revenue Growth | ★ 40.45 | N/A |
| 52 Week Low | $15.86 | $3.35 |
| 52 Week High | $30.96 | $6.20 |
| Indicator | ACAD | AVAL |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 21.96 |
| Support Level | $15.86 | $3.35 |
| Resistance Level | $22.71 | $4.57 |
| Average True Range (ATR) | 1.20 | 0.22 |
| MACD | -0.11 | -0.07 |
| Stochastic Oscillator | 18.38 | 4.27 |
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its segments include: Banking Services segment comprises Banking Services, fund management and trust businesses, storage companies and entities that manage low-value payment systems. Merchant Banking segment comprises Financial Sector (trust and brokerage), Gas and Energy Sector (includes natural gas and energy transportation and distribution businesses), Infrastructure Sector (includes road infrastructure projects, construction services, and operation and maintenance), Hotel Sector (includes hospitality services), Agribusiness Sector (includes palm oil, rubber and rice businesses). Pension and Severance Fund Management segment comprise administrator of pension and severance funds; and Holding segment.